Related Experiment Video
Updated: Jun 5, 2025

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
Serratia marcescens Prosthetic Valve Endocarditis: Portending a Dismal Course
Selma Siagh1, Najlaa Belharty1, Hasna Rami1
1Department of Cardiology B, Ibn Sina Hospital, Rabat, MAR.
Abstract:
Serratia marcescens, an opportunist pathogen mainly isolated in healthcare-associated infections, is a rare cause of infective endocarditis (IE) that generates an increased mortality rate compared to the usual agents. We report a case of a 70-year-old male patient who underwent a mitral valve replacement and was readmitted two months later with a high-grade continuous fever and deterioration of the general status. The diagnosis of early IE due to S. marcescens was established upon further investigation. The patient was treated with ertapenem and underwent surgery. Nevertheless, the prognosis was not favorable. Due to the rarity of similar presentations and the grim prognosis that S. marcescens IE portends, further investigation on this subject is warranted. This can aid in preventing future occurrences and help issue guidelines for therapeutic management, especially in patients with prosthetic valves.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Endocarditis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Endocarditis IV: Nursing Management

